JenniferLynn(Reifel)MalinMD
Oncology • Los Angeles, CAAssociate Professor, Medicine, UCLA School of Medicine
Dr. Malin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11301 Wilshire Blvd
West Los Angeles Healthcare Center
Los Angeles, CA 90073Phone+1 310-478-3711
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1995 - 1999- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1992 - 1995
David Geffen School of Medicine at UCLAClass of 1992
Certifications & Licensure
AZ State Medical License 2023 - 2026
MI State Medical License 2023 - 2026
TX State Medical License 2023 - 2026
AR State Medical License 2024 - 2025
CA State Medical License 1993 - 2025
KY State Medical License 2024 - 2025
LA State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsMeasure Scan and Synthesis of Palliative and End-of-Life Process Quality Measures for Advanced Cancer.Claire E O'Hanlon, Charlotta Lindvall, Karl A. Lorenz, Karleen F. Giannitrapani, Melissa M. Garrido
JCO Oncology Practice. 2021-02-01 - Real-World Outcomes and Value of First-Line Therapy for Metastatic Non-Small Cell Lung Cancer†.Stacey DaCosta Byfield, Benjamin Chastek, Stephanie Korrer, Thomas Horstman, Jennifer Malin
Cancer Investigation. 2020-10-27 - 7 citationsCharting the Course: Use of Clinical Pathways to Improve Value in Cancer Care.Jennifer Malin
Journal of Clinical Oncology. 2020-02-01
Press Mentions
- The 16th Annual Personalized Medicine Conference at Harvard Medical School: FROM AN ENTERPRISE TO AN ERA – How the Emergence of COVID-19 Effects Personalized Medicine, November 17 – 18, 2021 • Harvard Medical School, Boston, MAMarch 7th, 2021
NCCN: Costly Innovative Cancer Therapies Pose New Challenges—Financial and OtherwiseMarch 22nd, 2019
NCCN 2019 Annual Conference Includes Focus on Patient Experience with Innovative Therapies, plus Updates on Biomarkers, Biosimilars, and the Latest Research on Cancer CareMarch 4th, 2019
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
